Notably, in patients with AD accompanied by past stroke lesions, plasma GFAP levels may be associated with the severity of cognitive impairment, and plasma NfL levels may reflect the severity of delusions as neuropsychological symptoms. The gene discussed is GFAP; the disease is Cognitive impairment.